Omkar Speciality Chemicals
OMKARCHEM NSE
Omkar Speciality Chemicals
CommoditiesNSE: OMKARCHEM BSE: 533317 Chemicals & Petrochemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹7.02 Cr
Volatility
Moderate
P/E Ratio
-0.6
EBITDA
₹82.20 Cr
Return on Equity
15.66%
Debt to Equity
0.17
Book Value
₹-83.12
52W High
₹7.91
52W Low
₹3.35
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.38 times its book value
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -81.4% over past five years.
- Working capital days have increased from -10,77,662 days to 2,39,805 days
Growth Rate
Revenue Growth
55.94% higher than
3Y
Net Income Growth
25.93% higher than
3Y
Cash Flow Change
-16.79%
ROE
8.75%
ROCE
29.7%
EBITDA Margin (Avg.)
-0.65%
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0.01 | 0 |
| Expenses | 0.22 | 0.11 | 0.35 | 0.43 | 0.13 | 0.09 | 0.15 | 0.25 | 0.2 | 0.37 | 0.11 | 0.19 | 0.14 |
| Operating Profit | -0.17 | -0.1 | -0.35 | -0.43 | -0.13 | -0.09 | -0.15 | -0.25 | -0.2 | -0.29 | -0.11 | -0.18 | -0.14 |
| OPM % | -340% | -1000% | — | — | — | — | — | — | — | -362.5% | — | -1800% | — |
| Other Income | 0 | 0.02 | 0.01 | 0.06 | 0.03 | 0.08 | 0.03 | 0.08 | 0.01 | 0 | 0.01 | 0.07 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.25 | 0.26 | 0.26 | 0.25 | 0.23 | 0.23 | 0.23 | 0.22 | 0.22 | 0.23 | 0.23 | 0.22 | 0.22 |
| PBT | -0.42 | -0.34 | -0.6 | -0.62 | -0.33 | -0.24 | -0.35 | -0.39 | -0.41 | -0.52 | -0.33 | -0.33 | -0.36 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.42 | -0.34 | -0.59 | -0.62 | -0.32 | -0.24 | -0.35 | -0.39 | -0.41 | -0.52 | -0.33 | -0.33 | -0.36 |
| EPS in Rs | -0.2 | -0.17 | -0.29 | -0.3 | -0.16 | -0.12 | -0.17 | -0.19 | -0.2 | -0.25 | -0.16 | -0.16 | -0.17 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 193 | 319 | 317 | 198 | 42.65 | 56.61 | 44.97 | 22.98 | 7.02 | 0.06 | 0 | 0.01 | 0.09 |
| Expenses | 164 | 274 | 360 | 241 | 43.95 | 56.86 | 37.59 | 28.69 | 9.64 | 1.11 | 0.62 | 0.87 | 0.81 |
| Operating Profit | 28.94 | 45.42 | -43.1 | -43.36 | -1.3 | -0.25 | 7.38 | -5.71 | -2.62 | -1.05 | -0.62 | -0.86 | -0.72 |
| OPM % | 14.97% | 14.24% | -13.61% | -21.94% | -3.05% | -0.44% | 16.41% | -24.85% | -37.32% | -1750% | — | -8600% | -800% |
| Other Income | 4.91 | 8.75 | -60.96 | -48.9 | 12.39 | 0.45 | 4.9 | 0.96 | -146 | 0.09 | 0.22 | 0.16 | 0.08 |
| Interest | 11.43 | 16.52 | 21.83 | 26.13 | 14.62 | 4.93 | 5.57 | 6.07 | 32.5 | 0 | 0 | 0 | 0 |
| Depreciation | 1.97 | 4.28 | 10.9 | 8.16 | 7.99 | 6.59 | 3.56 | 1.79 | 1.08 | 1.01 | 0.91 | 0.89 | 0.9 |
| PBT | 20.45 | 33.37 | -137 | -127 | -11.52 | -11.32 | 3.15 | -12.61 | -182 | -1.97 | -1.31 | -1.59 | -1.54 |
| Tax % | 12.27% | 33.44% | -20.05% | -17.84% | 46.44% | 29.33% | 36.19% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | 17.93 | 22.21 | -109 | -104 | -16.87 | -14.63 | 2.01 | -12.61 | -182 | -1.97 | -1.3 | -1.59 | -1.54 |
| EPS in Rs | 8.7 | 10.78 | -53.09 | -50.47 | -8.19 | -7.1 | 0.98 | -6.12 | -88.37 | -0.96 | -0.63 | -0.77 | -0.74 |
| Div. Payout % | 17.22% | 13.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | — | 20.58 |
| Reserves | 142 | 161 | -23.39 | -146 | -169 | -183 | -179 | -192 | -374 | -376 | — | -1.85 |
| Borrowings | 176 | 186 | 181 | 233 | 230 | 233 | 228 | 226 | 382 | 382 | — | 3.11 |
| Other Liabilities | 50.13 | 79.52 | 135 | 28.48 | 25.77 | 26.45 | 16.61 | 17.71 | 17.24 | 22.08 | — | 23.81 |
| Total Liabilities | 389 | 447 | 313 | 136 | 107 | 97.27 | 86.37 | 72.17 | 46.37 | 49.23 | — | 45.65 |
| Fixed Assets | 68.3 | 77.9 | 168 | 76.29 | 68.43 | 53.14 | 27.91 | 26.12 | 21.88 | 20.86 | — | 19.07 |
| CWIP | 107 | 113 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0.2 |
| Investments | 13.8 | 13.91 | 0.14 | 10.92 | 0.35 | 0.38 | 0.71 | 0.43 | 0.07 | 0.07 | — | 0.07 |
| Other Assets | 199 | 242 | 145 | 48.9 | 38.41 | 43.75 | 57.75 | 45.62 | 24.42 | 28.3 | — | 26.31 |
| Total Assets | 389 | 447 | 313 | 136 | 107 | 97.27 | 86.37 | 72.17 | 46.37 | 49.23 | — | 45.65 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 52.85 | -9.4 | 107 | 25.96 | 1.38 | 4.02 | -16.41 | 0.89 | -124 | 0.2 | 0.91 | -1.6 |
| Investing | -76.06 | 11.71 | -120 | -64.33 | 10.9 | 1.51 | 17.35 | 0.17 | 0.29 | -0.17 | 0.11 | -0.13 |
| Financing | 17.33 | -7.91 | 15.75 | 35.24 | -13.55 | -5.3 | -1.08 | -1.04 | 124 | 0 | 0 | -0.05 |
| Net Cash Flow | -5.88 | -5.59 | 3.16 | -3.13 | -1.28 | 0.23 | -0.14 | 0.03 | 0.5 | 0.03 | 1.02 | -1.78 |
| Free Cash Flow | -13.54 | -28.61 | 46.77 | -28.42 | 1.26 | 5.52 | 0.82 | 0.89 | -121 | 0.13 | 0.91 | -1.8 |
| CFO/OP | 187 | -26 | -233 | -61 | -106 | -1,608 | -222 | -16 | 4,740 | -19 | -147 | 186 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 129 | 117 | 90.1 | 19.02 | 74.37 | 30.05 | 111 | 32.56 | 9.36 | 0 | — | 0 |
| Inventory Days | 149 | 99.08 | 110 | 7.51 | 37.27 | 31.46 | 17.96 | 39.78 | 7.28 | 60.83 | — | 365 |
| Days Payable | 96.33 | 81.02 | 139 | 31.59 | 259 | 148 | 139 | 215 | 903 | 63,510 | — | 0 |
| Cash Conversion Cycle | 181 | 135 | 61.14 | -5.05 | -147 | -86.17 | -10.05 | -143 | -886 | -63,449 | — | 365 |
| Working Capital Days | -89.12 | 38.3 | 9.86 | -296 | -1,361 | -1,002 | -1,065 | -3,296 | -20,208 | -23,95,130 | — | 2,39,805 |
| ROCE % | 10.11% | 14.14% | -18.99% | -34.48% | -8.32% | -8.47% | 6.66% | -10.53% | -8.42% | -7% | — | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Omkar Speciality Chemicals insights
62 extracted metrics + investor summaries across FY10–FY26.
Documents
1
Intimation With Respect To The Broad Step Plan For Capital Reduction, Issue And Allot Shares To The Resolution Applicant ('RA') And Achieving Of Minimum Public Shareholding ('MPS').
28 Apr - Broad step plan under CIRP: capital reduced to nil, fresh shares issued to RA, 5% OFS for MPS. 28 Apr - Broad step plan under CIRP: capital reduced to nil, fresh shares issued to RA, 5% OFS for MPS.
2
Intimation With Respect To The Broad Step Plan For Capital Reduction, Issue And Allot Shares To The Resolution Applicant ('RA') And Achieving Of Minimum Public Shareholding ('MPS').
28 Apr - Broad step plan under CIRP: capital reduced to nil, fresh shares issued to RA, 5% OFS for MPS. 28 Apr - Broad step plan under CIRP: capital reduced to nil, fresh shares issued to RA, 5% OFS for MPS.
3
Board Meeting Outcome for Outcome Of The Meeting Of Monitoring Committee Of Omkar Speciality Chemicals Limited ('The Company') Held On Wednesday, April 15, 2026
15 Apr - Record date 29 Apr 2026 fixed for share cancellation; 50 lakh shares issued, ₹20 crore loan, CFO/CS appointed. 15 Apr - Record date 29 Apr 2026 fixed for share cancellation; 50 lakh shares issued, ₹20 crore loan, CFO/CS appointed.
5
Appointment of Company Secretary and Compliance Officer
15 Apr - Record date set for share cancellation on Apr 29, 2026; 50 lakh shares issued, ₹20 crore loan approved. 15 Apr - Record date set for share cancellation on Apr 29, 2026; 50 lakh shares issued, ₹20 crore loan approved.
5
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On 14Th August 2026 10 Aug 2026
Intimation
Frequently Asked Questions about Omkar Speciality Chemicals
What does Omkar Speciality Chemicals Ltd do?
Incorporated in 1993, Omkar Specialty Chemicals Ltd is a global specialty chemicals company.[1]
Where is Omkar Speciality Chemicals Ltd (OMKARCHEM) listed?
Omkar Speciality Chemicals Ltd trades as OMKARCHEM on the NSE and under code 533317 on the BSE.
Which sector does Omkar Speciality Chemicals Ltd belong to?
Omkar Speciality Chemicals Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
What is the market capitalisation of Omkar Speciality Chemicals Ltd?
Omkar Speciality Chemicals Ltd has a market capitalisation of ₹7.02 Cr, which places it in the Small Cap band.
What is the PE ratio of Omkar Speciality Chemicals Ltd?
Omkar Speciality Chemicals Ltd trades at a PE ratio of -0.60, against a book value of ₹-83.12 per share.
What is the 52-week high and low of Omkar Speciality Chemicals Ltd?
Over the last 52 weeks Omkar Speciality Chemicals Ltd has traded between ₹3.35 and ₹7.91.
What is the Return on Equity (ROE) of Omkar Speciality Chemicals Ltd?
Omkar Speciality Chemicals Ltd reported a return on equity of 15.66%. Its debt-to-equity ratio is 0.17.
Company Information
Incorporated in 1993, Omkar Specialty Chemicals Ltd is a global specialty chemicals company.[1]
Website omkarchemicals.com
CEO Mr. Vaman G. Acharya
Listed 2011-02-10
Face Value ₹ 10
Issued Size 2,05,78,004
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/OMKARCHEM.md for Omkar Speciality Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.